Development of Flightless antibody therapy for treating wounds [ 2008 - 2010 ]

Also known as: Development of novel treatment for wounds

Research Grant

[Cite as]

Researchers: Prof Allison Cowin (Principal investigator) ,  Prof Heddy Zola

Brief description Chronic wounds, diabetic ulcers, injuries in response to trauma, burns and scalds form a medical need which will only expand as the population ages and the diabetic epidemic grows. In our studies, we have shown that Flightless I (FliI), an actin-remodelling protein, is a negative regulator of incisional wound healing. We are now developing a new antibody therapy to reduce FliI levels in wounds thereby leading to improved wound repair outcomes.

Funding Amount $AUD 194,071.03

Funding Scheme NHMRC Development Grants

Notes Development Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]